Cite
MLA Citation
Heli Gao et al.. “The optimal duration of capecitabine plus temozolomide in patients with well‐differentiated pancreatic NETs with or without maintenance therapy.” Journal of neuroendocrinology, vol. 34, 2022, p. n/a. http://access.bl.uk/ark:/81055/vdc_100158615499.0x00003f